Cargando…

Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope

BACKGROUND: Nasotracheal intubation is the most commonly used method to secure the field of view when performing surgery on the oral cavity or neck. Like orotracheal intubation, nasotracheal intubation uses a laryngoscope. Hemodynamic change occurs due to the stimulation of the sympathetic nervous s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Ji-Young, Park, Chul-Gue, Kim, Eun-Jung, Choi, Byung-Moon, Yoon, Ji-Uk, Kim, Yeon Ha, Lee, Moon Ok, Han, Ki Seob, Ahn, Ji-Hye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dental Society of Anesthsiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470995/
https://www.ncbi.nlm.nih.gov/pubmed/32934985
http://dx.doi.org/10.17245/jdapm.2020.20.4.195
_version_ 1783578687867715584
author Yoon, Ji-Young
Park, Chul-Gue
Kim, Eun-Jung
Choi, Byung-Moon
Yoon, Ji-Uk
Kim, Yeon Ha
Lee, Moon Ok
Han, Ki Seob
Ahn, Ji-Hye
author_facet Yoon, Ji-Young
Park, Chul-Gue
Kim, Eun-Jung
Choi, Byung-Moon
Yoon, Ji-Uk
Kim, Yeon Ha
Lee, Moon Ok
Han, Ki Seob
Ahn, Ji-Hye
author_sort Yoon, Ji-Young
collection PubMed
description BACKGROUND: Nasotracheal intubation is the most commonly used method to secure the field of view when performing surgery on the oral cavity or neck. Like orotracheal intubation, nasotracheal intubation uses a laryngoscope. Hemodynamic change occurs due to the stimulation of the sympathetic nervous system. Recently, video laryngoscope with a camera attached to the end of the direct laryngoscope blade has been used to minimize this change. In this study, we investigated the optimal effect-site concentration (Ce) of remifentanil for minimizing hemodynamic responses during nasotracheal intubation with a video laryngoscope. METHODS: Twenty-one patients, aged between 19 and 60 years old, scheduled for elective surgery were included in this study. Anesthesia was induced by slowly injecting propofol. At the same time, remifentanil infusion was initiated at 3.0 ng/ml via target-controlled infusion (TCI). When remifentanil attained the preset Ce, nasotracheal intubation was performed using a video laryngoscope. The patient's blood pressure and heart rate were checked pre-induction, right before and after intubation, and 1 min after intubation. Hemodynamic stability was defined as an increase in systolic blood pressure and heart rate by 20% before and after nasotracheal intubation. The response of each patient determined the Ce of remifentanil for the next patient at an interval of 0.3 ng/ml. RESULTS: The Ce of remifentanil administered ranged from 2.4 to 3.6 ng/ml for the patients evaluated. The estimated optimal effective effect-site concentrations of remifentanil were 3.22 and 4.25 ng/ml, that were associated with a 50% and 95% probability of maintaining hemodynamic stability, respectively. CONCLUSION: Nasotracheal intubation using a video laryngoscope can be successfully performed in a hemodynamically stable state by using the optimal remifentanil effect-site concentration (Ce(50), 3.22 ng/ml; Ce(95), 4.25 ng/ml).
format Online
Article
Text
id pubmed-7470995
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Dental Society of Anesthsiology
record_format MEDLINE/PubMed
spelling pubmed-74709952020-09-14 Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope Yoon, Ji-Young Park, Chul-Gue Kim, Eun-Jung Choi, Byung-Moon Yoon, Ji-Uk Kim, Yeon Ha Lee, Moon Ok Han, Ki Seob Ahn, Ji-Hye J Dent Anesth Pain Med Original Article BACKGROUND: Nasotracheal intubation is the most commonly used method to secure the field of view when performing surgery on the oral cavity or neck. Like orotracheal intubation, nasotracheal intubation uses a laryngoscope. Hemodynamic change occurs due to the stimulation of the sympathetic nervous system. Recently, video laryngoscope with a camera attached to the end of the direct laryngoscope blade has been used to minimize this change. In this study, we investigated the optimal effect-site concentration (Ce) of remifentanil for minimizing hemodynamic responses during nasotracheal intubation with a video laryngoscope. METHODS: Twenty-one patients, aged between 19 and 60 years old, scheduled for elective surgery were included in this study. Anesthesia was induced by slowly injecting propofol. At the same time, remifentanil infusion was initiated at 3.0 ng/ml via target-controlled infusion (TCI). When remifentanil attained the preset Ce, nasotracheal intubation was performed using a video laryngoscope. The patient's blood pressure and heart rate were checked pre-induction, right before and after intubation, and 1 min after intubation. Hemodynamic stability was defined as an increase in systolic blood pressure and heart rate by 20% before and after nasotracheal intubation. The response of each patient determined the Ce of remifentanil for the next patient at an interval of 0.3 ng/ml. RESULTS: The Ce of remifentanil administered ranged from 2.4 to 3.6 ng/ml for the patients evaluated. The estimated optimal effective effect-site concentrations of remifentanil were 3.22 and 4.25 ng/ml, that were associated with a 50% and 95% probability of maintaining hemodynamic stability, respectively. CONCLUSION: Nasotracheal intubation using a video laryngoscope can be successfully performed in a hemodynamically stable state by using the optimal remifentanil effect-site concentration (Ce(50), 3.22 ng/ml; Ce(95), 4.25 ng/ml). The Korean Dental Society of Anesthsiology 2020-08 2020-08-27 /pmc/articles/PMC7470995/ /pubmed/32934985 http://dx.doi.org/10.17245/jdapm.2020.20.4.195 Text en Copyright © 2020 Journal of Dental Anesthesia and Pain Medicine http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yoon, Ji-Young
Park, Chul-Gue
Kim, Eun-Jung
Choi, Byung-Moon
Yoon, Ji-Uk
Kim, Yeon Ha
Lee, Moon Ok
Han, Ki Seob
Ahn, Ji-Hye
Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
title Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
title_full Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
title_fullStr Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
title_full_unstemmed Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
title_short Optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
title_sort optimal effect-site concentration of remifentanil to prevent hemodynamic changes during nasotracheal intubation using a video laryngoscope
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470995/
https://www.ncbi.nlm.nih.gov/pubmed/32934985
http://dx.doi.org/10.17245/jdapm.2020.20.4.195
work_keys_str_mv AT yoonjiyoung optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT parkchulgue optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT kimeunjung optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT choibyungmoon optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT yoonjiuk optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT kimyeonha optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT leemoonok optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT hankiseob optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope
AT ahnjihye optimaleffectsiteconcentrationofremifentaniltopreventhemodynamicchangesduringnasotrachealintubationusingavideolaryngoscope